| Financial Year |
March 31 2023 |
| Monetary Funds |
210,473,661.78 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
131,548,759.57 |
| Advances to Suppliers |
7,803,317.56 |
| Other Receivables |
3,328,475.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
109,098,512.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,860,753.76 |
| Total Current Assets |
466,989,974.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
10,393,828.26 |
| Fixed Assetes |
466,642,708.70 |
| Under-construction Projects |
65,610,231.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,451,351.59 |
| R&D expenses |
-- |
| Goodwill |
2,363,394.56 |
| Long-Term Deferred and Prepaid Expenses |
4,165,059.57 |
| Deferred Income Tax Assets |
6,385,200.35 |
| Other Non-Current Assets |
1,500,000.00 |
| Sub-Total of Non-Current Assets |
607,511,775.02 |
| Total Assets |
1,074,501,749.89 |
| Short-Term Loans |
70,307,341.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
16,180,000.00 |
| Accounts Payable |
114,483,680.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,803,243.80 |
| Taxes Payable |
9,634,974.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
783,748.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
846,209.71 |
| Sub-Total of Current Liabilities |
229,548,503.74 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,853,337.67 |
| Total Liabilities |
237,401,841.41 |
| Paid-In Capital(Or Share Stock) |
149,205,000.00 |
| Capital Surplus |
457,588,256.72 |
| Surplus Reserve |
29,616,986.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
183,902,533.02 |
| Minority Stockholder's Interest |
16,787,131.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
820,312,776.56 |
| Owner's Equity（Stockholder's Equity） |
837,099,908.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,074,501,749.89 |
